Skip to main content
Orchid Pharma Limited logo

Orchid Pharma Limited — Investor Relations & Filings

Ticker · ORCHPHARMA ISIN · INE191A01027 LEI · 33580076KIKCYSLZVF05 BSE.NS Manufacturing
Open in API
Filings indexed 451 across all filing types
Latest filing 2023-08-09 AGM Information
Country IN India
Listing BSE.NS ORCHPHARMA

About Orchid Pharma Limited

https://www.orchidpharma.com/

Orchid Pharma Limited is a vertically integrated organization focused on the development, manufacture, and marketing of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs). The company specializes in the anti-infectives segment, with a particular emphasis on cephalosporins and penicillins. Its operations span the entire value chain, including advanced research and development, process chemistry, and large-scale manufacturing. Orchid Pharma maintains facilities that adhere to rigorous international regulatory standards, enabling the supply of high-quality generic formulations and complex molecules to global markets. The company prioritizes innovation in chemical synthesis and formulation development to address complex therapeutic requirements and enhance healthcare outcomes through a robust portfolio of essential medicines.

Recent filings

Filing Released Lang Actions
Shareholders meeting
AGM Information Classification · 95% confidence The document is titled as "Proceedings of the 30th Annual General Meeting (AGM) of Orchid Pharma Limited" and details the conduct of the AGM held on August 9, 2023. It includes information about the meeting format (video conferencing), attendance, agenda items, resolutions proposed, and procedural details such as voting and scrutinizer appointment. The document does not contain financial statements or detailed financial analysis but rather a summary and procedural record of the AGM. It also references the Notice of the AGM and mentions that voting results will be submitted later. This matches the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including proceedings. The document length is substantial and contains detailed AGM proceedings, not just an announcement or a brief note. Therefore, the correct classification is AGM-R with high confidence.
2023-08-09 English
Board Meeting — ORCHID PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 10-Aug-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the…
Regulatory Filings
2023-08-04 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a short notice dated August 4, 2023, addressed to stock exchanges, informing about a scheduled Board of Directors meeting on August 10, 2023, to consider and approve the unaudited financial results for the quarter ended June 30, 2023. It also mentions the trading window closure period. The document is an intimation under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to board meeting announcements and related disclosures. The document does not contain the financial results themselves, only a notice of the upcoming board meeting and results approval. The length is only 1567 characters, indicating it is a brief announcement rather than a full report. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a regulatory announcement about an upcoming event and not the financial report itself.
2023-08-04 English
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document is a communication addressed to stock exchanges (NSE and BSE) regarding a newspaper advertisement for the book closure and e-voting process for the 30th Annual General Meeting (AGM) of Orchid Pharma Limited. It references prior announcements and provides details about the AGM notice, cut-off date, and e-voting information in compliance with relevant company law and SEBI regulations. The document is essentially an announcement about the AGM process and related voting procedures, not the AGM materials themselves or the results of voting. It is also not a full report or transcript but a formal notification to exchanges and the public. Therefore, the document fits best into the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or related announcements about the AGM process.
2023-07-19 English
Shareholders meeting
AGM Information Classification · 95% confidence The document is a Notice of the 30th Annual General Meeting (AGM) of Orchid Pharma Limited scheduled for August 9, 2023. It includes details about the agenda items such as adoption of audited financial statements for the fiscal year ended March 31, 2023, appointment of directors, approval of remuneration, shifting of registered office, and related party transactions. The document references regulatory compliance with SEBI and MCA circulars allowing the AGM to be held via video conferencing. The document is a formal notice inviting shareholders to the AGM and includes explanatory statements and resolutions to be considered at the meeting. It does not contain the full annual report or financial statements themselves but refers to them as part of the agenda. The document length is about 15,000 characters, which is consistent with a detailed AGM notice. Therefore, this document fits the category of AGM Information (AGM-R) as it is the notice and explanatory statement for the AGM, not the full annual report or other filings.
2023-07-18 English
Book Closure
AGM Information Classification · 95% confidence The document is an intimation letter about the scheduling of the 30th Annual General Meeting (AGM) of Orchid Pharma Limited. It provides details about the date, e-voting, and other procedural information related to the AGM. It mentions that the AGM Notice along with the Annual Report will be dispatched later and submitted in due course, indicating that this document itself is not the Annual Report or the AGM materials but an announcement about the AGM event and related voting procedures. The document length is short (2728 characters) and primarily serves as a notification to the stock exchanges and shareholders. Therefore, it fits the category of AGM Information (AGM-R) as it relates to the AGM event and its arrangements, not the actual Annual Report or voting results.
2023-07-13 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.